Morphometry of the dorsal raphe nucleus serotonergic neurons in suicide victims

Biological Psychiatry

Volumn 46, Issue 4, 1999, Pages 473-483

  Underwood, Mark D ^a,b   Khaibulina, Alfia A ^a   Ellis, Steven P ^a   Moran, Andrew ^a   Rice, Patricia M ^c   Mann, J John ^a,b   Arango, Victoria ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Department of Psychiatry Coll Phys Surgs of Columbia Univ ^*  (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Brainstem; Mental illness; Neuromorphometry; Quantitation; Serotonin; Suicide

Indexed keywords

SEROTONIN;

ADULT; ARTICLE; BRAIN STEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MEASUREMENT; MORPHOMETRICS; PRIORITY JOURNAL; RAPHE NUCLEUS; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SUICIDAL BEHAVIOR; SUICIDE;

EID: 0032768819     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00043-8     Document Type: Article

References (96)

1. Ågren H. Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid I. General patterns . Psychiatry Res. 3:1980;211-223.
2. Ågren H. Life at risk markers of suicidality in depression . Psychiatry Dev. 1:1983;87-103.
3. Åsberg M., Träskman L., Thorn P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry. 33:1976;1193-1197.
4. Aletrino M.A., Vogels O.J.M., Van Domburg P.H.M.F., Ten Donkelaar H.J. Cell loss in the nucleus raphes dorsalis in Alzheimer's disease. Neurobiol Aging. 13:1992;461-468.
5. Amenta F., Zaccheo D., Collier W.L. Neurotransmitters, neuroreceptors and aging. Mech Ageing Dev. 61:1991;249-273.
6. Andersson A., Eriksson A., Marcusson J. Unaltered number of brain serotonin uptake sites in suicide victims. J Psychopharmacol. 6:1992;509-513.
7. Appel N.M., Mitchell W.M., Contrera J.F., De Souza E.B. Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain Assessment using quantitative autoradiography . Synapse. 6:1990;33-44.
8. 2 and -adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry. 47:1990;1038-1047.
9. Arango V., Underwood M.D., Gubbi A.V., Mann J.J. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688:1995;121-133.
10. Arató M., Tekes K., Palkovits M., Demeter E., Falus A. Serotonergic split brain and suicide. Psychiatry Res. 21:1987;355-356.
11. Arató M., Tekes K., Tóthfalusi L., Magyar K., Palkovits M., Frecska E., et al. Reversed hemispheric asymmetry of imipramine binding in suicide victims. Biol Psychiatry. 29:1991;699-702.
12. 3H]-imipramine binding in the frontal cortex of suicides. Psychiatry Res. 30:1989;125-135.
13. Arora R.C., Meltzer H.Y. Serotonergic measures in the brains of suicide victims 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects . Am J Psychiatry. 146:1989;730-736.
14. 3H]-imipramine binding studies in the frontal cortex of normal controls and suicide victims . Biol Psychiatry. 29:1991;1016-1022.
15. Baker K.G., Halliday G.M., Hornung J.-P., Geffen L.B., Cotton R.G.H., Törk I. Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus. Neuroscience. 42:1991;757-775.
16. Baker K.G., Halliday G.M., Kril J.J., Harper C.G. Chronic alcoholics without Wernicke-Korsakoff syndrome or cirrhosis do not lose serotonergic neurons in the dorsal raphe nucleus. Alcohol Clin Exp Res. 20:1996;61-66.
17. Baker K.G., Halliday G.M., Törk I. Cytoarchitecture of the human dorsal raphe nucleus. J Comp Neurol. 301:1990;147-161.
18. Banki C.M., Arató M., Papp Z., Kurcz M. Biochemical markers in suicidal patients. Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests. J Affect Disord. 6:1984;341-350.
19. Bobillier P., Petitjean F., Salvert D., Ligier M., Seguin S. Differential projections of the nucleus raphe dorsalis and nucleus raphe centralis as revealed by autoradiography. Brain Res. 85:1975;205-210.
20. Bourne H.R., Bunney W.E. Jr, Colburn R.W., Davis J.M., Shaw D.M., Coppen A.J. Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients. Lancet. ii:1968;805-808.
21. Brown G.L., Ebert M.H., Goyer P.F., Jimersom D.C., Klein W.J., Bunney W.E. Jr, et al. Aggression, suicide and serotonin relationships to CSF amine metabolites . Am J Psychiatry. 139:1982;741-746.
22. Castellanos J., Elia J., Kruesi M., Gulotta C.S., Mefford I.N., Potter W.Z., et al. Cerebrospinal fluid monamine metabolites in boys with attention-deficit hyperactivity disorder. Psychiatry Res. 52:1994;305-316.
23. 1 binding sites in depressed suicides. Psychopharmacology. 102:1990;544-548.
24. Clarke A.S., Kammerer C.M., George K.P., Kupfer D.J., McKinney W.T., Spence M.A., et al. Evidence for heritability of biogenic amine levels in the cerebrospinal fluid of Rhesus monkeys. Biol Psychiatry. 38:1995;572-577.
25. Coccaro E.F., Siver L.J., Owen K., Davis K.L. Serotonin in mood and personality disorders. Coccaro E.F., Murphy D.L. Serotonin in Major Psychiatric Disorders. 1990;71-97 APA Press, Washington, DC.
26. Colado M.I., Murray T.K., Green A.R. 5-HT loss in rat brain following 3,4- methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine. Br J Pharmacol. 108:1993;583-589.
27. Conrad L.C.A., Leonard C.M., Pfaff D.W. Connections of the median and dorsal raphe nuclei in the rat an autoradiographic and degeneration study . J Comp Neurol. 156:1974;179-206.
28. Conwell Y., Raby W.N., Caine E.D. Suicide and aging. II The psychobiological interface . Int Psychogeriatrics. 7:1995;165-181.
29. Cowburn R.F., Marcusson J.O., Eriksson A., Wiehager B., O'Neill C. Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims. Brain Res. 633:1994;297-304.
30. Crow T.J., Cross A.J., Cooper S.J., Deakin J.F.W., Ferrier I.N., Johnson J.A., et al. Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides. Neuropharmacology. 23:1984;1561-1569.
31. De Souza E.B., Battaglia G., Insel T.R. Neurotoxic effects of MDMA on brain serotonin neurons evidence from neurochemical and radioligand binding studies . Ann NY Acad Sci. 600:1990;682-698.
32. 1A receptor binding in the human brain postmortem effects of age and alcohol . Brain Res. 554:1991;56-64.
33. Egeland J.A., Sussex J.N. Suicide and family loading for affective disorders. J Am Med Assoc. 254:1985;915-918.
34. Fischer C., Hatzidimitriou G., Wlos J., Katz J., Ricaurte G. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (±)3,4- methylenedioxymethamphetamine (MDMA, "ecstasy"). J Neurosci. 15:1995;5476-5485.
35. Gross-Isseroff R., Israeli M., Biegon A. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem effects of suicide . Arch Gen Psychiatry. 46:1989;237-241.
36. 3H]ketanserin binding in the human brain postmortem effect of suicide . Brain Res. 507:1990;208-215.
37. Gundersen H.J.G., Bendtsen T.F., Korbo L., Marcussen N., Moller A., Nielsen K., et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS. 96:1988;379-394.
38. Haan E.A., Jennings I.G., Cuello A.C., Nakata H., Fujisawa H., Chow C.W., et al. Identification of serotonergic neurons in human brain by a monoclonal antibody binding to all three aromatic amino acid hydroxylases. Brain Res. 426:1987;19-27.
39. Halliday G., Ellis J., Heard R., Caine D., Harper C. Brainstem serotonergic neurons in chronic alcoholics with and without the memory impairment of Korsakoff's psychosis. J Neuropathol Exp Neurol. 52:1993;567-579.
40. Halperin J.M., Sharma V., Siever L.J., Schwartz S.T., Matier K., Wornell G., et al. Serotonergic function in aggressive and nonaggressive boys with attention deficit hyperactivity disorder. Am J Psychiatry. 151:1994;243-248.
41. Higley J.D., Thompson W.W., Champoux M., Goldman D., Hasert M.F., Kraemer G.W., et al. Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in Rhesus monkeys (Macaca mulatta). Arch Gen Psychiatry. 50:1993;615-623.
42. Holden R.J. Schizophrenia, suicide and the serotonin story. Med Hypotheses. 44:1995;379-391.
43. 2 sites in cortex and amygdala . Brain Res. 614:1993;37-44.
44. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques a comparison between ABC and unlabeled antibody (PAP) procedures . J Histochem Cytochem. 29:1981;577-580.
45. Johnson M.P., Nichols D.E. Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administration. Pharmacol Biochem Behav. 33:1989;105-108.
46. Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE (1993): Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8:315-336. Kleven MS, Seiden LS (1989): D-, L- and DL-Fenfluramine cause long-lasting depletions of serotonin in rat brain. Brain Res 505:351-353.
47. Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE (1993): Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8:315-336. Kleven MS, Seiden LS (1989): D-, L- and DL-Fenfluramine cause long-lasting depletions of serotonin in rat brain. Brain Res 505:351-353.
48. Konigsmark B.W. Method for the counting of neurons. Nauta W.J.H., Ebbeson S.O.E. Contemporary Research Method in Neuroanatomy. 1970;315-380 Springer, New York.
49. Kraemer G.W. Psychobiology of early social attachment in Rhesus monkeys. Clinical implications. Ann NY Acad Sci. 807:1997;401-418.
50. Laruelle M., Abi-Dargham A., Casanova M.F., Toti R., Weinberger D.R., Kleinman J.E. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia a postmortem study . Arch Gen Psychiatry. 50:1993;810-818.
51. 3H]paroxetine, in antidepressant-free depressed suicides. Brain Res. 526:1990;17-22.
52. 3H]paroxetine binding sites in postmortem human brain from controls and suicides. Biol Psychiatry. 28:1990;544-546.
53. Littell R.C., Milliken G.A., Stroup W.W., Wolfinger R.D. SAS System for Mixed Models. 1996;SAS Institute Inc, Cary, NC.
54. Little K.Y., McLauglin D.P., Ranc J., Gilmore J., Lopez J.F., Watson S.J., et al. Serotonin transporter binding sites and mRNA levels in depressed persons committing suicide. Biol Psychiatry. 41:1997;1156-1164.
55. Lloyd K.G., Farley I.J., Deck J.H.N., Hornykiewicz O. Serotonin and 5-hydroxyindoleacetic acid in discrete areas of the brainstem of suicide victims and control patients. Adv Biochem Psychopharmacol. 11:1974;387-397.
56. Mann J.J., Arango V., Marzuk P.M., Theccanat S., Reis D.J. Evidence for the 5-HT hypothesis of suicide a review of post-mortem studies . Br J Psychiatry. 155:(Suppl. 8):1989;7-14.
57. 3H]-Paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high-affinity, non-transporter sites. J Neural Transm. 103:1996;1337-1350.
58. Mann J.J., Malone K.M. Cerebrospinal fluid amines and higher lethality suicide attempts in depressed inpatients. Biol Psychiatry. 41:1997;162-171.
59. 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 43:1986;954-959.
60. Mann J.J., Underwood M.D., Arango V. Postmortem studies of suicide victims. Watson S.J. Biology of Schizophrenia and Affective Disease. 1st ed. 1996;197-220 American Psychiatric Press, Inc, Washington, DC.
61. 1A binding sites in frontal cortex of suicide victims . J Neural Transm. 85:1991;181-194.
62. McEntee W.J., Crook T.H. Serotonin, memory, and the aging brain. Psychopharmacology. 103:1991;143-149.
63. Meyerson L.R., Wennogle L.P., Abel M.S., Coupet J., Lippa A.S., Rauh C.E., et al. Human brain receptor alterations in suicide victims. Pharmacol Biochem Behav. 17:1982;159-163.
64. Molliver D.C., Molliver M.E. Anatomic evidence for a neurotoxic effect of (+/-)-fenfluramine upon serotonergic projections in the rat. Brain Res. 511:1990;165-168.
65. Montgomery S.A. The psychopharmacology of borderline personality disorders. Acta Psychiatr Belg. 87:1987;260-266.
66. 1B receptor mRNA levels in the rat dorsal raphe nucleus. Biol Psychiatry. 41:1997;668-674.
67. Ninan P.T., van Kammen D.P., Scheinin M., Linnoila M., Bunney W.E. Jr, Goodwin F.K. CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. Am J Psychiatry. 141:1984;566-569.
68. Owen F., Chambers D.R., Cooper S.J., Crow T.J., Johnson J.A., Lofthouse R., et al. Serotonergic mechanisms in brains of suicide victims. Brain Res. 362:1986;185-188.
69. 2 receptors and suicide. Lancet. ii:1983;1256-1256.
70. Pacheco M.A., Stockmeier C.A., Meltzer H.Y., Overholser J.C., Dilley G.E., Jope R.S. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res. 723:1996;37-45.
71. Pare C.M.B., Yeung D.P.H., Price K., Stacey R.S. 5-Hydroxytryptamine, noradrenaline, and dopamine in brainstem, hypothalamus, and caudate nucleus of controls and of patients committing suicide by coal-gas poisoning. Lancet. ii:1969;133-135.
72. Pierce E.T., Foote W.E., Hobson J.A. The efferent connection of the nucleus raphe dorsalis. Brain Res. 107:1976;137-144.
73. 2A) receptor characteristics and parenting factors for boys at risk for delinquency a preliminary report . Am J Psychiatry. 153:1996;538-544.
74. Pine D.S., Coplan J.D., Wasserman G.A., Miller L.S., Fried J.E., Davies M., et al. Neuroendocrine response to fenfluramine challenge in boys associations with aggressive behavior and adverse rearing . Arch Gen Psychiatry. 54:1997;839-846.
75. Ricaurte G.A., Forno L.S., Wilson M.A., DeLanney L.E., Irwin I., Molliver M.E., et al. ±3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. J Am Med Assoc. 260:1988;51-55.
76. Roy A., Ågren H., Pickar D., Linnoila M., Doran A., Cutler N., et al. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients Relationship to suicidal behavior and dexamethasone nonsuppression . Am J Psychiatry. 143:1986;1539-1545.
77. Roy A., Lamparski D., De Jong J., Adinoff B., Ravitz B., George D.T., et al. Cerebrospinal fluid monoamine metabolites in alcoholic patients who attempt suicide. Acta Psychiatr Scand. 81:1990;58-61.
78. Roy A., Pollack S. Are cerebrospinal fluid or urinary monoamine metabolite measures stronger correlates of suicidal behavior in depression. Neuropsychobiology. 29:1994;164-167.
79. Sakai K., Salvert D., Touret M., Jouvet M. Afferent connections of the nucleus raphe dorsalis in the cat as visualized by the horseradish peroxidase technique. Brain Res. 137:1977;11-35.
80. Schulsinger F., Kety S.S., Rosenthal D., Wender P.H. A family study of suicide. Schou M., Stromgren E. Origin, Prevention and Treatment of Affective Disorders. 1979;277-287 Academic Press, New York.
81. Shaw D.M., Camps F.E., Eccleston E.G. 5-Hydroxytryptamine in the hind-brain of depressive suicides. Br J Psychiatry. 113:1967;1407-1411.
82. Sotelo C. Immunohistochemical study of short- and long-term effects of DL- fenfluramine on the serotonergic innervation of the rat hippocampal formation. Brain Res. 541:1991;309-326.
83. Stanley M., Mann J.J. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet. i:1983;214-216.
84. Stanley M., Virgilio J., Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science. 216:1982;1337-1339.
85. Stockmeier CA, Meltzer HY (1995): Biologic studies of suicide in schizophrenia. Clin Neuropharmacol 18(Suppl.)3:S9-S17.
86. Törk I. Anatomy of the serotonergic system. Ann NY Acad Sci. 600:1990;9-35.
87. Törk I., Halliday G.M., Cotton R.G.H. Application of antiphenylalanine hydroxylase antibodies to the study of the serotonergic system in the human brain. J Chem Neuroanat. 3:1992;311-313.
88. Törk I., Hornung J.-P. Raphe nuclei and the serotonergic system. Paxinos G. The Human Nervous System. 1990;1001-1022 Academic Press, San Diego.
89. Träskman L., Åsberg M., Bertilsson L., Sjöstrand L. Monoamine metabolites in CSF and suicidal behavior. Arch Gen Psychiatry. 38:1981;631-636.
90. van Praag H.M. CSF 5-HIAA and suicide in non-depressed schizophrenics. Lancet. ii:1983;977-978.
91. Virkkunen M., De Jong J., Bartko J., Linnoila M. Psychobiological concomitants of history of suicide attempts among violent offenders and impulsive fire setters. Arch Gen Psychiatry. 46:1989;604-606.
92. Wender P.H., Kety S.S., Rosenthal D., Schulsinger F., Ortmann J., Lunde I. Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry. 43:1986;923-929.
93. West M.J. New stereological methods for counting neurons. Neurobiol Aging. 14:1993;275-285.
94. Wilson M.A., Molliver M.E. The organization of serotonergic projections to cerebral cortex in primates regional distribution of axon terminals . Neuroscience. 44:1991;537-553.
95. Wilson M.A., Molliver M.E. The organization of serotonergic projections to cerebral cortex in primates retrograde transport studies . Neuroscience. 44:1991;555-570.
96. 2 receptor changes in major depression. Biol Psychiatry. 27:1990;489-496.